Serum Uric Acid may be Associated with Left Ventricular Diastolic Dysfunction in Military Individuals

Chung-Ming Tu1,2, Guo-Shiang Tseng3, Cheng-Wei Liu4,5

  • 1Cardiology Division of Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City 22060, Taiwan.

Military Medicine
|October 31, 2020
PubMed

Insights

High serum uric acid (SUA) is linked to left ventricular diastolic dysfunction (LVDD) in military personnel. Keeping SUA levels normal may help prevent LVDD development.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Serum uric acid (SUA) is a metabolic byproduct.
  • Left ventricular diastolic dysfunction (LVDD) is a common cardiac condition.
  • The relationship between SUA and LVDD in military populations is not well-established.

Purpose of the Study:

  • To investigate the correlation between serum uric acid levels and left ventricular diastolic dysfunction criteria.
  • To determine the association between elevated SUA and LVDD in military individuals.

Main Methods:

  • Prospective enrollment of 268 military individuals evaluated for electrocardiographic abnormalities.
  • Definition of hyperuricemia as SUA ≥7 mg/dL (men) or ≥6 mg/dL (women).
  • Assessment of LVDD criteria and left ventricular hypertrophy using echocardiographic guidelines.

Main Results:

  • Serum uric acid showed weak correlations with left atrial diameter and left ventricular mass index (LVMI).
  • The hyperuricemic group exhibited higher LVMI and increased prevalence of LVDD criteria (septal e' velocity <7 cm/s, lateral e' velocity <10 cm/s, average E/e' >14).
  • Elevated SUA was significantly associated with septal e' velocity <7 cm/s in multivariate analysis (adjusted HR: 2.398).

Conclusions:

  • Elevated serum uric acid is significantly associated with specific criteria for left ventricular diastolic dysfunction in military personnel.
  • Maintaining normal SUA levels may be a strategy to prevent the development of LVDD.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
270
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
202
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
221
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
245
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
283
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
250